203 related articles for article (PubMed ID: 12430209)
1. [Role of PKC in the pathogenesis of diabetic vascular complications].
Inoguchi T; Umeda F
Nihon Rinsho; 2002 Oct; 60 Suppl 10():67-72. PubMed ID: 12430209
[No Abstract] [Full Text] [Related]
2. Molecule of the month. Ruboxistaurin mesilate hydrate.
Drug News Perspect; 2003 Dec; 16(10):691. PubMed ID: 14747848
[No Abstract] [Full Text] [Related]
3. Ruboxistaurin.
Taulien CA; Joy SV
Drugs Today (Barc); 2006 Sep; 42(9):577-85. PubMed ID: 17028667
[TBL] [Abstract][Full Text] [Related]
4. Ruboxistaurin, a protein kinase C beta inhibitor, as an emerging treatment for diabetes microvascular complications.
Joy SV; Scates AC; Bearelly S; Dar M; Taulien CA; Goebel JA; Cooney MJ
Ann Pharmacother; 2005 Oct; 39(10):1693-9. PubMed ID: 16160002
[TBL] [Abstract][Full Text] [Related]
5. Ruboxistaurin for diabetic retinopathy.
Gardner TW; Antonetti DA
Ophthalmology; 2006 Dec; 113(12):2135-6. PubMed ID: 17157131
[No Abstract] [Full Text] [Related]
6. [Role of advanced glycation end products and activation of PKC in diabetic retinopathy].
Kaji Y; Oshika T
Nihon Rinsho; 2005 Jun; 63 Suppl 6():188-93. PubMed ID: 15999705
[No Abstract] [Full Text] [Related]
7. Protein kinase C beta inhibitors: a new therapeutic target for diabetic nephropathy and vascular complications.
Budhiraja S; Singh J
Fundam Clin Pharmacol; 2008 Jun; 22(3):231-40. PubMed ID: 18485142
[TBL] [Abstract][Full Text] [Related]
8. [New prospects in the treatment of diabetic retinopathy. Current situation and pharmacological developments].
Lagrèze WA
MMW Fortschr Med; 2003 Apr; 145(14):37-8. PubMed ID: 15072277
[No Abstract] [Full Text] [Related]
9. PKC inhibition and diabetic microvascular complications.
Clarke M; Dodson PM
Best Pract Res Clin Endocrinol Metab; 2007 Dec; 21(4):573-86. PubMed ID: 18054736
[TBL] [Abstract][Full Text] [Related]
10. [Protein kinase C beta-Inhibitor ruboxistaurin].
Musch A
Med Monatsschr Pharm; 2005 Aug; 28(8):292-3. PubMed ID: 16128544
[No Abstract] [Full Text] [Related]
11. The role of protein kinase C activation and the vascular complications of diabetes.
Das Evcimen N; King GL
Pharmacol Res; 2007 Jun; 55(6):498-510. PubMed ID: 17574431
[TBL] [Abstract][Full Text] [Related]
12. New hope for the treatment of diabetic complications.
Corder R
Clin Sci (Lond); 2002 Sep; 103(3):323-4. PubMed ID: 12193158
[No Abstract] [Full Text] [Related]
13. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
Sahu AK; Majji AB
Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6890; author reply 6890-1. PubMed ID: 21123772
[No Abstract] [Full Text] [Related]
14. [Potential pharmacological treatments for diabetic retinopathy].
Watanabe D; Takagi H
Nihon Rinsho; 2005 Jun; 63 Suppl 6():244-9. PubMed ID: 15999714
[No Abstract] [Full Text] [Related]
15. Protein kinase C inhibition and diabetic retinopathy: a shot in the dark at translational research.
Donnelly R; Idris I; Forrester JV
Br J Ophthalmol; 2004 Jan; 88(1):145-51. PubMed ID: 14693793
[TBL] [Abstract][Full Text] [Related]
16. Treatment of diabetic retinopathy with protein kinase C subtype Beta inhibitor.
Lang GE
Dev Ophthalmol; 2007; 39():157-165. PubMed ID: 17245085
[TBL] [Abstract][Full Text] [Related]
17. The potential role of PKC beta in diabetic retinopathy and macular edema.
Aiello LP
Surv Ophthalmol; 2002 Dec; 47 Suppl 2():S263-9. PubMed ID: 12507628
[TBL] [Abstract][Full Text] [Related]
18. Potential new medical therapies for diabetic retinopathy: protein kinase C inhibitors.
Frank RN
Am J Ophthalmol; 2002 May; 133(5):693-8. PubMed ID: 11992868
[TBL] [Abstract][Full Text] [Related]
19. Effect of ruboxistaurin on the visual acuity decline associated with long-standing diabetic macular edema.
Davis MD; Sheetz MJ; Aiello LP; Milton RC; Danis RP; Zhi X; Girach A; Jimenez MC; Vignati L;
Invest Ophthalmol Vis Sci; 2009 Jan; 50(1):1-4. PubMed ID: 18708615
[TBL] [Abstract][Full Text] [Related]
20. [Development of therapeutic agents for diabetic neuropathies].
Nakamura J
Nihon Rinsho; 2005 Jun; 63 Suppl 6():614-21. PubMed ID: 15999780
[No Abstract] [Full Text] [Related]
[Next] [New Search]
